Abstract:Objective To investigate the clinical features of children with incomplete Kawasaki disease (IKD), and to provide reference for the early diagnosis of IKD. Methods The clinical data of 22 hospitalized children with IKD were analyzed retrospectively and compared with the data of 63 children with Kawasaki disease (KD) who were hospitalized during the same period of time. Another 20 children with pyrexia were enrolled as the control group. Results Pyrexia was observed in all children. Compared with the KD group, the IKD group had significantly lower proportions of children with changes in the limbs, conjunctival hyperaemia, and cervical lymphadenectasis (P < 0.05), a significantly higher serum level of glutamic-pyruvic transaminase (P < 0.05), and significantly lower levels of plasma albumin, serum sodium, and interleukin-6 (P < 0.05). There was no significant difference in the rate of γ-globulin application between the IKD and KD groups; however, the IKD group had a significantly higher incidence rate of coronary artery lesion than the KD group (P < 0.05). Conclusions The symptoms and signs in children with IKD are untypical. The liver function test and serum hyponatremia and IL-6 measurements may be useful for the diagnosis of IKD.
Choi Y,Eun LY,Oh SH.Incomplete Kawasaki disease in a 12-month-old girl presenting with cardiac murmur and iron deficiency anemia[J].Pediatr Int,2016,58(5):377-379.
[2]
Sánchez-Manubens J,Bou R,Anton J.Diagnosis and classification of Kawasaki disease[J].J Autoimmun,2014,48-49:113-117.
[3]
Yeom JS,Woo HO,Park JS,et al.Kawasaki disease in infants[J].Korean J Pediatr,2013,56(9):377-382.
Ebbeson RL,Riley MR,Potts JE,et al.Kawasaki disease at British Columbia's Children's Hospital[J].Paediatr Child Health,2004,9(7):466-470.
[6]
Tseng WN,Lo MH,Guo MM et al.IL-31 associated with coronary artery lesion formation in Kawasaki disease[J].PLoS One,2014,9(8):e105195.
[7]
Shah V,Christov G,Mukasa T,et al.Cardiovascular status after Kawasaki disease in the UK[J].Heart,2015,101(20):1646-1655.
[8]
Newburger JW,Takahashi M,Beiser AS,et al.A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome[J].N Engl J Med,1991,324(23):1633-1639.
[9]
Tacke CE,Breunis WB,Pereira RR et al.Five years of Kawasaki disease in the Netherlands:a national surveillance study[J].Pediatr Infect Dis J,2014,33(8):793-797.
Liu L,Yin W,Wang R,et al.The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease:a meta-analysis[J].Inflamm Res,2016,65(2):161-168.
Sudo D,Monobe Y,Yashiro M,et al.Coronary artery lesions of incomplete Kawasaki disease:a nationwide survey in Japan[J].Eur J Pediatr,2012,171(4):651-656.
[16]
Takahara T,Shimizu M,Nakagishi Y,et al.Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease[J].Rheumatol Int,2015,35(1):81-84.